Radiosensitization and DNA repair inhibition by pentoxifylline in NIH3T3 p53 transfectants

被引:9
作者
Binder, A
Theron, T
Donninger, H
Parker, M
Bohm, L
机构
[1] Univ Stellenbosch, Dept Radiat Oncol, Radiobiol Lab, Fac Hlth, ZA-7505 Tygerberg, South Africa
[2] Tygerberg Hosp, ZA-7505 Tygerberg, South Africa
[3] Univ Cape Town, Fac Hlth Sci, Dept Biochem Med, ZA-7925 Cape Town, South Africa
关键词
D O I
10.1080/0955300021000016369
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: To examine the role of p53 mutations in the modulation of DNA repair and radiotoxicity by pentoxifylline. Materials and methods: NIH3T3 murine cells transfected with mutant p53 constructs were examined for the influence of pentoxifylline on radiotoxicity to Co-60 gamma-irradiation by colony assay. DNA repair (0-100 Gy) was measured by constant-field gel electrophoresis. Apoptosis was assessed by flow cytometry with the an nexin-V-binding assay. Results: In the two p53 hot-spot mutant cell lines p53-S269R and p53- + 15, the SF10 radiotoxicity enhancement factors induced by the pentoxifylline were 8.0 and 9.7, respectively. In the 1:63 deletion mutant p53-DeltaA cell line, the radiotoxicity enhancement factor was 2.6. No radiosensitization was obtained in the untransfected p53 wild-type cell line U-Wt and in the transfected p53 double-wild-type p53-Wt cell line. When pentoxifylline was added after irradiation at the time of maximum G2 block expression, no radiosensitization was observed in any of the five cell lines. Constant-field gel electrophoresis analyses after 20 h of repair showed that pentoxifylline suppresses DNA double-strand break repair in all p53 mutant cell lines, as indicated by repair inhibition factors of 2.0-2.3. No repair suppression was found in the p53 wild-type cell lines. Conclusions: p53 mutations are a general requirement for radiosensitization by pentoxifylline and the level of radiosensitization depends upon the location of the p53 mutation.
引用
收藏
页码:991 / 1000
页数:10
相关论文
共 38 条
[21]  
POWELL SN, 1995, CANCER RES, V55, P1643
[22]  
Roos WP, 2000, INT J RADIAT BIOL, V76, P1493, DOI 10.1080/09553000050176252
[23]   Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant [J].
Rowan, S ;
Ludwig, RL ;
Haupt, Y ;
Bates, S ;
Lu, X ;
Oren, M ;
Vousden, KH .
EMBO JOURNAL, 1996, 15 (04) :827-838
[24]   Preferential radiosensitization of G1 checkpoint - Deficient cells by methylxanthines [J].
Russell, KJ ;
Wiens, LW ;
Demers, GW ;
Galloway, DA ;
Le, T ;
Rice, GC ;
Bianco, JA ;
Singer, JW ;
Groudine, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 36 (05) :1099-1106
[25]  
RUSSELL KJ, 1995, CANCER RES, V55, P1639
[26]   Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest [J].
Ryan, KM ;
Vousden, KH .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) :3692-3698
[27]   The C-terminus of mutant p53 is necessary for its ability to interfere with growth arrest or apoptosis [J].
Sigal, A ;
Matas, D ;
Almog, N ;
Goldfinger, N ;
Rotter, V .
ONCOGENE, 2001, 20 (35) :4891-4898
[28]   THE EFFECT OF RADIATION ON G(2) BLOCKS, CYCLIN-B EXPRESSION AND CDC2 EXPRESSION IN HUMAN SQUAMOUS CARCINOMA CELL-LINES WITH DIFFERENT RADIOSENSITIVITIES [J].
SMEETS, MFMA ;
MOOREN, EHM ;
BEGG, AC .
RADIOTHERAPY AND ONCOLOGY, 1994, 33 (03) :217-227
[29]  
Soussi T, 2000, ANN NY ACAD SCI, V910, P121
[30]  
Tempel K, 1997, Z NATURFORSCH C, V52, P466